HIGHLIGHTS
- who: Christopher A. Darlow from the Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool , BE, UK have published the research work: Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings, in the Journal: (JOURNAL) of 21/Dec/2021
- what: A PD interaction model based on the model described by Greco26 was fitted to the data.
SUMMARY
Strains were selected based on having MICs ≤32 mg/L and >0.0625 mg/L to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.